{
    "2021-12-06": [
        [
            {
                "time": "",
                "original_text": "泰格医药(03347.HK)获摩根大通增持18.37万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "摩根大通",
                        "增持"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "2021年基金，买了个“寂寞”",
                "features": {
                    "keywords": [
                        "基金",
                        "2021年",
                        "寂寞"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "粤开策略深度 | 医药生物行业2022年展望：价值重鸣，创新为锋",
                "features": {
                    "keywords": [
                        "粤开策略",
                        "医药生物",
                        "2022年展望",
                        "价值重鸣",
                        "创新为锋"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：医保谈判落地 释放积极信号",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保谈判",
                        "落地",
                        "积极信号"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}